Search Result "treatment 1"
Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists
Journal: Current Diabetes Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 266-275
Author(s): Urd Kielgast, Jens J. Holst, Sten Madsbad
Activating Protein-1 (AP-1): A Promising Target for the Treatment ofFibrotic Diseases
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 7 Year: 2024 Page: 904-918
Author(s):
Inhibition of Interleukin-1 in the Treatment of Selected Cardiovascular Complications
Journal: Current Reviews in Clinical and Experimental Pharmacology
Volume: 16 Issue: 3 Year: 2021 Page: 219-227
Author(s): Fatemeh Sadat Heydari,Simin Zare,Ali Roohbakhsh
Potential of Angiotensin-(1-7) in COVID-19 Treatment
Journal: Current Protein & Peptide Science
Volume: 24 Issue: 1 Year: 2023 Page: 89-97
Author(s):
A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 6 Year: 2010 Page: 504-516
Author(s): M. Munoz, M. Rosso, R. Covenas
GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 2 Year: 2024 Page: 100-114
Author(s):
The Strategy of Immunologic Control of HIV-1 with Structured Treatment Interruptions (STIs)
Journal: Current Drug Targets - Infectious Disorders
Volume: 1 Issue: 1 Year: 2001 Page: 11-17
Author(s): Ronald B. Moss, Fred C. Jensen, Dennis J. Carlo, Mark. R. Wallace
Inhibitors of HIV-1 Entry and Integration: Recent Developments and Impact on Treatment
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 7 Issue: 2 Year: 2013 Page: 151-161
Author(s): Anil K. Sharma, Varghese George, Ranjini Valiathan, Sudheesh Pilakka-Kanthikeel, Suresh Pallikkuth
An Overview of Interleukin-1 Receptor Antagonist, Anakinra, in the Treatment of Cutaneous Diseases
Journal: Current Clinical Pharmacology
Volume: 7 Issue: 4 Year: 2012 Page: 271-275
Author(s): Nader Pazyar, Amir Feily, Reza Yaghoobi